<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We consecutively recruited 21 patients (<z:hpo ids='HP_0000001'>all</z:hpo> women, mean 54 +/- 8 years) with bath-related thunderclap <z:hpo ids='HP_0002315'>headache</z:hpo> (BRTH) </plain></SENT>
<SENT sid="1" pm="."><plain>Thirteen of them were in menopause, two had just ceased hormonal therapy, and one was at 3 months postpartum </plain></SENT>
<SENT sid="2" pm="."><plain>Bathing was the initial trigger for thunderclap <z:hpo ids='HP_0002315'>headaches</z:hpo> in nine patients (43%) </plain></SENT>
<SENT sid="3" pm="."><plain>Many patients (n = 15, 71%) had other non-bath-related attacks </plain></SENT>
<SENT sid="4" pm="."><plain>Most patients (n = 18, 86%) reported that the <z:hpo ids='HP_0002315'>headache</z:hpo> occurred immediately when water was sprayed over their body, with warm water (52%) as the most common </plain></SENT>
<SENT sid="5" pm="."><plain>During the disease course [mean 14 days (6-34)], the mean number of BRTH was 5.1 +/- 3.6 attacks </plain></SENT>
<SENT sid="6" pm="."><plain>Nineteen patients (90%) changed bathing habits to prevent attacks </plain></SENT>
<SENT sid="7" pm="."><plain>Thirteen patients (62%) had magnetic resonance angiography vasoconstrictions, and two of them (15%) developed reversible posterior <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>None of the patients without vasoconstrictions had this complication </plain></SENT>
<SENT sid="9" pm="."><plain>Nimodipine was effective in stopping further attacks in 84% (16/19) treated patients </plain></SENT>
<SENT sid="10" pm="."><plain>No relapse was reported at a mean follow-up of 30 months </plain></SENT>
<SENT sid="11" pm="."><plain>BRTH occurred exclusively in women and predominantly in middle age </plain></SENT>
<SENT sid="12" pm="."><plain>Deficiency or fluctuation of female sex hormones may play a role </plain></SENT>
<SENT sid="13" pm="."><plain>About 60% patients showed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasms</z:e>, fulfilling the diagnosis of reversible cerebral vasoconstriction syndrome and indicating a risk of posterior <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> </plain></SENT>
</text></document>